Rani Therapeutics Holdings appointed Nicholas Maestas as Chief Financial Officer effective immediately, succeeding Svai Sanford, who announced his departure in May 2026. The update is primarily leadership/operations-focused with no disclosed financial guidance or operating metrics in the release.
Rani Therapeutics Holdings appointed Nicholas Maestas as Chief Financial Officer effective immediately, succeeding Svai Sanford, who announced his departure in May 2026. The update is primarily leadership/operations-focused with no disclosed financial guidance or operating metrics in the release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
